Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bruce, D"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 200
Tytuł:
Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection.
Autorzy:
Muema DM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Akilimali NA; Africa Health Research Institute, Durban, South Africa.
Ndumnego OC; Africa Health Research Institute, Durban, South Africa.
Rasehlo SS; Africa Health Research Institute, Durban, South Africa.
Durgiah R; Africa Health Research Institute, Durban, South Africa.
Ojwach DBA; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Ismail N; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Dong M; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Moodley A; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Dong KL; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA.
Ndhlovu ZM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA.
Mabuka JM; Africa Health Research Institute, Durban, South Africa.
Walker BD; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA.
Mann JK; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Ndung'u T; Africa Health Research Institute, Durban, South Africa. .; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa. .; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA. .; Max Planck Institute for Infection Biology, Berlin, Germany. .; Division of Infection and Immunity, University College London, London, UK. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2020 Mar 25; Vol. 18 (1), pp. 81. Date of Electronic Publication: 2020 Mar 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytokines/*therapeutic use
HIV Infections/*immunology
Viral Load/*methods
Viremia/*immunology
Adolescent ; Adult ; Cytokines/pharmacology ; Female ; HIV Infections/drug therapy ; Humans ; Male ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.
Autorzy:
Caskey M; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Klein F; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Lorenzi JC; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
West AP Jr; Division of Biology, California Institute of Technology, Pasadena, California 91125, USA.
Buckley N; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Kremer G; 1] First Department of Internal Medicine, University Hospital of Cologne, D-50924 Cologne, Germany [2] Clinical Trials Center Cologne, ZKS Köln, BMBF 01KN1106, University of Cologne, Cologne, Germany.
Nogueira L; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Braunschweig M; 1] Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA [2] Albert Ludwigs University of Freiburg, 79085 Freiburg, Germany.
Scheid JF; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Horwitz JA; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Shimeliovich I; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Ben-Avraham S; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Witmer-Pack M; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Platten M; 1] First Department of Internal Medicine, University Hospital of Cologne, D-50924 Cologne, Germany [2] German Center for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany.
Lehmann C; 1] First Department of Internal Medicine, University Hospital of Cologne, D-50924 Cologne, Germany [2] German Center for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany.
Burke LA; 1] Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA [2] Division of Infectious Diseases, Weill Medical College of Cornell University, New York, New York 10065, USA.
Hawthorne T; Celldex Therapeutics, Inc., Hampton, New Jersey 08827, USA.
Gorelick RJ; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.
Walker BD; Ragon Institute of MGH, MIT and Harvard, Howard Hughes Medical Institute, Massachusetts General Hospital and Harvard Medical School, Cambridge, Massachusetts 02139, USA.
Keler T; Celldex Therapeutics, Inc., Hampton, New Jersey 08827, USA.
Gulick RM; Division of Infectious Diseases, Weill Medical College of Cornell University, New York, New York 10065, USA.
Fätkenheuer G; 1] First Department of Internal Medicine, University Hospital of Cologne, D-50924 Cologne, Germany [2] German Center for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany.
Schlesinger SJ; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Nussenzweig MC; 1] Laboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA [2] Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10065, USA.
Pokaż więcej
Źródło:
Nature [Nature] 2015 Jun 25; Vol. 522 (7557), pp. 487-91. Date of Electronic Publication: 2015 Apr 08.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing/*immunology
HIV Antibodies/*immunology
HIV Infections/*therapy
HIV-1/*immunology
Viral Load/*immunology
Viremia/*therapy
Adult ; Amino Acid Sequence ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/pharmacokinetics ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antibodies, Neutralizing/administration & dosage ; Antibodies, Neutralizing/adverse effects ; Antibodies, Neutralizing/pharmacology ; Antibodies, Neutralizing/therapeutic use ; Binding Sites ; Broadly Neutralizing Antibodies ; CD4 Antigens/metabolism ; Case-Control Studies ; Evolution, Molecular ; Female ; HIV Antibodies/administration & dosage ; HIV Antibodies/adverse effects ; HIV Antibodies/pharmacology ; HIV Antibodies/therapeutic use ; HIV Envelope Protein gp120/chemistry ; HIV Envelope Protein gp120/immunology ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/chemistry ; HIV-1/drug effects ; Humans ; Immunization, Passive/methods ; Male ; Middle Aged ; Molecular Sequence Data ; Time Factors ; Viral Load/drug effects ; Viremia/immunology ; Viremia/virology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.
Autorzy:
Kiepiela P; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4013, South Africa.
Ngumbela K
Thobakgale C
Ramduth D
Honeyborne I
Moodley E
Reddy S
de Pierres C
Mncube Z
Mkhwanazi N
Bishop K
van der Stok M
Nair K
Khan N
Crawford H
Payne R
Leslie A
Prado J
Prendergast A
Frater J
McCarthy N
Brander C
Learn GH
Nickle D
Rousseau C
Coovadia H
Mullins JI
Heckerman D
Walker BD
Goulder P
Pokaż więcej
Źródło:
Nature medicine [Nat Med] 2007 Jan; Vol. 13 (1), pp. 46-53. Date of Electronic Publication: 2006 Dec 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Viral Load*
CD8-Positive T-Lymphocytes/*immunology
HIV Infections/*metabolism
Viral Proteins/*metabolism
Adult ; Female ; Gene Products, env/metabolism ; Gene Products, gag/metabolism ; HIV Infections/immunology ; HIV Infections/virology ; HLA Antigens/metabolism ; Humans ; Male ; South Africa ; Viremia/immunology ; Viremia/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of HLA class I functional divergence on HIV control.
Autorzy:
Viard M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
O'hUigin C; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
Yuki Y; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
Bashirova AA; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
Collins DR; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Urbach JM; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Wolinsky S; Division of Infectious Diseases, Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Buchbinder S; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.; Department of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Kirk GD; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Michael NL; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Haas DW; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Deeks SG; Department of Medicine, University of California, San Francisco, CA, USA.
Walker BD; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Yu X; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Jan 19; Vol. 383 (6680), pp. 319-325. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Heterozygote*
HIV Infections*/genetics
HIV Infections*/pathology
HLA-B Antigens*/genetics
Humans ; Alleles ; Disease Progression ; Peptides/genetics ; Peptides/immunology ; Male ; Female ; Young Adult ; Adult ; Middle Aged ; Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Centering PrEP: utilizing ADAPT-ITT to inform group PrEP care for sex workers in Chicago.
Autorzy:
Singer RB; College of Nursing, University of Illinois Chicago (UIC), Chicago, IL, USA. .
Barrow J; College of Nursing, University of Illinois Chicago (UIC), Chicago, IL, USA.
Johnson AK; Lurie Children's Hospital, Chicago, IL, USA.
Zemlak J; College of Nursing, Marquette University, Milwaukee, WI, USA.
Crooks N; College of Nursing, University of Illinois Chicago (UIC), Chicago, IL, USA.
Abboud S; College of Nursing, University of Illinois Chicago (UIC), Chicago, IL, USA.
Bruce D; College of Science and Health, DePaul University, Chicago, IL, USA.
Green N; Chicago Center for HIV Elimination, Chicago, IL, USA.
Stamps J; Southside Health Advocacy Resource Partnership, Chicago, IL, USA.
Neely J; Northwestern Memorial Hospital, Chicago, IL, USA.
Sherman SG; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Patil CL; College of Nursing, University of Illinois Chicago (UIC), Chicago, IL, USA.; School of Nursing, University of Michigan, Ann Arbor, USA.
Matthews AK; School of Nursing, Columbia University, New York, NY, USA.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Jan 02; Vol. 24 (1), pp. 56. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sex Workers*
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Pre-Exposure Prophylaxis*
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Pregnancy ; Chicago ; Delivery of Health Care
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Protectins PCTR1 and PD1 Reduce Viral Load and Lung Inflammation During Respiratory Syncytial Virus Infection in Mice.
Autorzy:
Walker, Katherine H.
Krishnamoorthy, Nandini
Brüggemann, Thayse R.
Shay, Ashley E.
Serhan, Charles N.
Levy, Bruce D.
Pokaż więcej
Temat:
RESPIRATORY syncytial virus infections
LIQUID chromatography-mass spectrometry
PNEUMONIA
VIRAL load
LECTINS
Źródło:
Frontiers in Immunology; 8/19/2021, Vol. 12, p1-15, 15p
Czasopismo naukowe
Szczegóły
Tytuł:
Integrating hypertension and HIV care in Namibia: A quality improvement collaborative approach.
Autorzy:
Basenero A; Ministry of Health and Social Services, Windhoek, Namibia.
Neidel J; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
Ikeda DJ; Harvard Medical School, Boston, Massachusetts, United States of America.
Ashivudhi H; U.S. Centers for Disease Control and Prevention, Windhoek, Namibia.
Mpariwa S; Ministry of Health and Social Services, Windhoek, Namibia.
Kamangu JWN; Ministry of Health and Social Services, Windhoek, Namibia.
Mpalang Kakubu MA; Ministry of Health and Social Services, Windhoek, Namibia.
Hans L; U.S. Centers for Disease Control and Prevention, Windhoek, Namibia.
Mutandi G; U.S. Centers for Disease Control and Prevention, Windhoek, Namibia.
Jed S; Office of the U.S. Global AIDS Coordinator and Health Diplomacy, Pretoria, South Africa.
Tjituka F; Ministry of Health and Social Services, Windhoek, Namibia.
Hamunime N; Ministry of Health and Social Services, Windhoek, Namibia.
Agins BD; Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Aug 11; Vol. 17 (8), pp. e0272727. Date of Electronic Publication: 2022 Aug 11 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hypertension*/drug therapy
Hypertension*/therapy
Adult ; Antihypertensive Agents/therapeutic use ; Humans ; Namibia/epidemiology ; Quality Improvement
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
Autorzy:
Vieira VA; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Adland E; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Malone DFG; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Martin MP; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
Groll A; Department of Statistics, TU Dortmund University, Dortmund, Germany.
Ansari MA; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Garcia-Guerrero MC; IrsiCaixa AIDS Research Institute, Badalona, Spain.
Puertas MC; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER en Enfermedades Infecciosas, Madrid, Spain.
Muenchhoff M; Max von Pettenkofer Institute & Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.; German Center for Infection Research (DZIF), partner site Munich, Munich, Germany.
Guash CF; Infectious Diseases and Systemic Inflammatory Response in Pediatrics, Infectious Diseases Unit, Department of Pediatrics, Sant Joan de Déu Hospital Research Foundation, Barcelona, Spain.; Center for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Pediatrics, University of Barcelona, Barcelona, Spain.; Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain.
Brander C; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER en Enfermedades Infecciosas, Madrid, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
Martinez-Picado J; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER en Enfermedades Infecciosas, Madrid, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
Bamford A; Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Tudor-Williams G; Department of Infectious Diseases, Imperial College, London, United Kingdom.
Ndung'u T; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Africa Health Research Institute (AHRI), Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Max Planck Institute for Infection Biology, Chariteplatz, Berlin, Germany.; Division of Infection and Immunity, University College London, London, United Kingdom.
Walker BD; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Africa Health Research Institute (AHRI), Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Ramsuran V; School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Frater J; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Oxford NIHR Biomedical Research Centre, Oxford, United Kingdom.
Jooste P; Department of Paediatrics, Kimberley Hospital, Kimberley, South Africa.
Peppa D; Division of Infection and Immunity, University College London, London, United Kingdom.
Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Goulder PJR; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2021 Nov 18; Vol. 17 (11), pp. e1010090. Date of Electronic Publication: 2021 Nov 18 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
CD8-Positive T-Lymphocytes/*immunology
HIV Infections/*immunology
HIV-1/*immunology
HLA-B Antigens/*immunology
Histocompatibility Antigens Class I/*immunology
Killer Cells, Natural/*immunology
Receptors, KIR3DL1/*metabolism
Adolescent ; Child ; Child, Preschool ; Cohort Studies ; HIV Infections/metabolism ; HIV Infections/virology ; Humans ; Lymphocyte Activation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Plasma cXcl13 but not B cell Frequencies in acute hiV infection Predicts emergence of crossneutralizing antibodies.
Autorzy:
Mabuka, Jenniffer M.
Dugast, Anne-Sophie
Muema, Daniel M.
Reddy, Tarylee
Ramlakhan, Yathisha
Euler, Zelda
Ismail, Nasreen
Moodley, Amber
Dong, Krista L.
Morris, Lynn
Walker, Bruce D.
Alter, Galit
Ndung'u, Thumbi
Pokaż więcej
Temat:
B cells
HIV infections
IMMUNOGLOBULINS
Źródło:
Frontiers in Immunology; 9/8/2017, p1-13, 13p
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 200

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies